/Becton%20Dickinson%20%26%20Co_%20BACTEC%20by-%20TheBlueHydrangea%20via%20Shutterstock.jpg)
Despite Becton, Dickinson and Company’s underperformance relative to its industry peers over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
/Boston%20Scientific%20Corp_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Due to Boston Scientific's strong performance relative to its industry peers over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
/Steris%20Plc%20logo%20and%20chart-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Despite STERIS’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects.
/Insulet%20Corporation%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Insulet has significantly outpaced the broader market over the past year, and analysts remain bullish on the stock’s prospects.
/Zimmer%20Biomet%20Holdings%20Inc%20HQ%20photo-by%20jetcityimage%20via%20iStock.jpg)
Zimmer Biomet has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
Despite Edwards Lifesciences’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
/Medtronic%20Plc%20logo-by%20360b%20via%20Shutterstock.jpg)
While Medtronic has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.
After a brutal last week on Trump tariff concerns, Wall Street attempted to bounce back on April 7. Invesco QQQ Trust QQQ added 0.24% in the key trading session and advanced 1.2% after hours. SPDR S&P...
/Teleflex%20Incorporated%20sign%20at%20office-by%20Tada%20Images%20via%20Shutterstock.jpg)
Due to Teleflex’s underperformance relative to its industry peers over the past six months, Wall Street analysts remain cautious about the stock’s prospects.